Prestige Consumer (PBH) | Financial Analysis & Statements
Prestige Consumer Healthcare Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
283.4M
Gross Profit
157.4M
55.52%
Operating Income
82.5M
29.10%
Net Income
46.7M
16.47%
EPS (Diluted)
$0.97
Balance Sheet Metrics
Total Assets
3.4B
Total Liabilities
1.6B
Shareholders Equity
1.8B
Debt to Equity
0.85
Cash Flow Metrics
Operating Cash Flow
47.5M
Free Cash Flow
58.4M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Prestige Consumer Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 1.1B | 1.1B | 1.1B | 943.4M |
| Cost of Goods Sold | 503.3M | 500.9M | 502.4M | 466.2M | 395.9M |
| Gross Profit | 634.5M | 624.4M | 625.3M | 620.6M | 547.5M |
| Gross Margin % | 55.8% | 55.5% | 55.4% | 57.1% | 58.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 263.9M | 259.5M | 252.4M | 264.8M | 223.7M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 263.9M | 259.5M | 252.4M | 264.8M | 223.7M |
| Operating Income | 349.2M | 342.4M | 347.8M | 331.0M | 299.8M |
| Operating Margin % | 30.7% | 30.4% | 30.8% | 30.5% | 31.8% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 47.6M | 67.2M | 69.2M | 64.3M | 82.3M |
| Other Non-Operating Income | -17.4M | 756.0K | -372.6M | -4.2M | -13.4M |
| Pre-tax Income | 284.2M | 276.0M | -93.9M | 262.5M | 204.1M |
| Income Tax | 69.6M | 66.7M | -11.6M | 57.1M | 39.4M |
| Effective Tax Rate % | 24.5% | 24.2% | 0.0% | 21.7% | 19.3% |
| Net Income | 214.6M | 209.3M | -82.3M | 205.4M | 164.7M |
| Net Margin % | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% |
| Key Metrics | |||||
| EBITDA | 374.5M | 373.9M | 378.1M | 362.0M | 331.4M |
| EPS (Basic) | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 |
| EPS (Diluted) | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 |
| Basic Shares Outstanding | 49697000 | 49757000 | 49889000 | 50259000 | 50210000 |
| Diluted Shares Outstanding | 49697000 | 49757000 | 49889000 | 50259000 | 50210000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Prestige Consumer Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 97.9M | 46.5M | 58.5M | 27.2M | 32.3M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 202.0M | 185.0M | 183.4M | 159.0M | 114.7M |
| Inventory | 147.7M | 138.7M | 162.1M | 120.3M | 115.0M |
| Other Current Assets | 8.4M | 13.1M | 4.1M | 6.4M | 7.9M |
| Total Current Assets | 448.3M | 375.0M | 391.7M | 293.3M | 269.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 53.3M | 12.8M | 19.1M | 27.2M | 32.7M |
| Goodwill | 3.4B | 3.4B | 3.4B | 3.9B | 3.6B |
| Intangible Assets | 2.3B | 2.3B | 2.3B | 2.7B | 2.5B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 3.3M | 5.7M | 3.0M | 3.3M | 2.9M |
| Total Non-Current Assets | 3.0B | 2.9B | 3.0B | 3.4B | 3.2B |
| Total Assets | 3.4B | 3.3B | 3.4B | 3.7B | 3.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 18.9M | 39.0M | 62.7M | 55.8M | 46.0M |
| Short-term Debt | 8.5M | 6.2M | 9.8M | 9.1M | 8.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 106.6M | 117.0M | 160.7M | 143.4M | 122.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.0B | 1.1B | 1.4B | 1.5B | 1.5B |
| Deferred Tax Liabilities | 419.6M | 403.6M | 380.4M | 444.9M | 434.0M |
| Other Non-Current Liabilities | 5.4M | 9.2M | 8.2M | 7.5M | 8.6M |
| Total Non-Current Liabilities | 1.5B | 1.5B | 1.7B | 1.9B | 1.9B |
| Total Liabilities | 1.6B | 1.7B | 1.9B | 2.1B | 2.1B |
| Equity | |||||
| Common Stock | 560.0K | 555.0K | 548.0K | 544.0K | 540.0K |
| Retained Earnings | 1.6B | 1.3B | 1.1B | 1.2B | 1.0B |
| Treasury Stock | 277.2M | 219.6M | 189.1M | 133.6M | 130.7M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.8B | 1.7B | 1.4B | 1.6B | 1.4B |
| Key Metrics | |||||
| Total Debt | 1.0B | 1.1B | 1.4B | 1.5B | 1.5B |
| Working Capital | 341.7M | 258.0M | 231.0M | 149.8M | 147.7M |
Balance Sheet Composition
Prestige Consumer Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 214.6M | 209.3M | -82.3M | 205.4M | 164.7M |
| Depreciation & Amortization | 30.2M | 30.7M | 32.6M | 32.1M | 30.2M |
| Stock-Based Compensation | 11.2M | 14.0M | 12.4M | 9.0M | 8.5M |
| Working Capital Changes | -53.6M | -15.4M | -66.9M | -22.0M | 12.5M |
| Operating Cash Flow | 227.2M | 273.1M | -153.8M | 245.4M | 238.8M |
| Investing Activities | |||||
| Capital Expenditures | -8.2M | -9.6M | -7.8M | -9.6M | -22.2M |
| Acquisitions | -9.2M | -10.6M | -3.8M | -246.9M | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -17.5M | -20.1M | -15.4M | -256.3M | -22.2M |
| Financing Activities | |||||
| Share Repurchases | -51.5M | -25.0M | -50.0M | 0 | -11.9M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 0 | 0 | 597.0M | 600.0M |
| Debt Repayment | -139.5M | -227.8M | -157.8M | -687.6M | -866.4M |
| Financing Cash Flow | -196.9M | -259.1M | -213.2M | -99.6M | -352.3M |
| Free Cash Flow | 243.3M | 239.4M | 221.9M | 250.3M | 213.4M |
| Net Change in Cash | 12.8M | -6.1M | -382.4M | -110.5M | -135.7M |
Cash Flow Trend
Prestige Consumer Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.18
Forward P/E
11.96
Price to Book
1.49
Price to Sales
2.51
PEG Ratio
-0.75
Profitability Ratios
Profit Margin
16.90%
Operating Margin
29.10%
Return on Equity
10.31%
Return on Assets
6.13%
Financial Health
Current Ratio
3.11
Debt to Equity
59.00
Beta
0.47
Per Share Data
EPS (TTM)
$3.79
Book Value per Share
$38.66
Revenue per Share
$22.52
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PBH | 2.8B | 15.18 | 1.49 | 10.31% | 16.90% | 59.00 |
| Zoetis | 49.8B | 19.58 | 15.04 | 65.99% | 28.24% | 279.59 |
| Haleon Plc - ADR | 42.4B | 18.72 | 1.88 | 10.27% | 15.11% | 52.37 |
| Alkermes plc | 5.6B | 23.71 | 3.09 | 14.72% | 16.37% | 3.85 |
| Lantheus Holdings | 5.4B | 24.30 | 4.91 | 21.45% | 15.15% | 57.19 |
| Amneal | 4.2B | 63.23 | -57.42 | -101.02% | 2.39% | 45,095.52 |
Financial data is updated regularly. All figures are in the company's reporting currency.






